BBNX
Financials
- Market Capitalization 887.2 M
- Employee 423
- Founded 2015
- CEO N/A
- Website www.betabionics.com
- Headquarter Delaware, United States
- FIGI BBG00JNGG9Q2
- Industry Medical Devices
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2494 |  INMD InMode Ltd. - Ordinary Shares | 14.85 USD | +0.07% | -1.39% | -3.45% | -3.32% | 940.88 M USD | ||
| 2504 |  CBLL CeriBell, Inc. - Common Stock | 23.73 USD | +1.54% | -1.94% | +33.31% | +83.67% | 910.71 M USD | ||
| 2542 |  SGP SpyGlass Pharma, Inc. - Common Stock | 26.23 USD | -2.60% | -1.43% | +22.28% | +9.29% | 877.34 M USD | ||
| 2563 |  SIBN SI-BONE, Inc. - Common Stock | 19.21 USD | +0.05% | -3.81% | +7.20% | +15.31% | 860.96 M USD |
Frequently asked questions about Beta Bionics, Inc. Common Stock
What is the Beta Bionics, Inc. Common Stock stock price today?
The current price of Beta Bionics, Inc. Common Stock (BBNX) is 19.72. Over the past 24 hours, the stock has changed by +0.92%. Follow the BBNX chart for real-time price dynamics.
What is the stock ticker of Beta Bionics, Inc. Common Stock?
Beta Bionics, Inc. Common Stock trades under the ticker BBNX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Beta Bionics, Inc. Common Stock stock going up?
BBNX has changed by +3.52% over the last week, +26.01% over the last month, and -7.24% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Beta Bionics, Inc. Common Stock?
Beta Bionics, Inc. Common Stock currently has a market capitalization of 887.2 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Beta Bionics, Inc. Common Stock earnings last quarter?
Last quarter, Beta Bionics, Inc. Common Stock reported earnings of -0.53 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Beta Bionics, Inc. Common Stock revenue for the last quarter?
Beta Bionics, Inc. Common Stock reported quarterly revenue of 32.01 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Beta Bionics, Inc. Common Stock net income for the last quarter?
Beta Bionics, Inc. Common Stock reported net income of -23.4 M for the last quarter. The previous quarter showed -21.89 M, which means net income changed by -6.89%.
How many employees does Beta Bionics, Inc. Common Stock have?
As of the latest available data, Beta Bionics, Inc. Common Stock has 423 employees. Workforce size can provide additional context about the company's scale and operations.
What is Beta Bionics, Inc. Common Stock EBITDA?
Beta Bionics, Inc. Common Stock EBITDA is -24.77 M, and its EBITDA margin is -77.39%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Beta Bionics, Inc. Common Stock stock?
You can buy Beta Bionics, Inc. Common Stock (BBNX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Beta Bionics, Inc. Common Stock stock?
Investing in Beta Bionics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BBNX chart and related analysis on metatrader.com as part of your research.